ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Convexity subarachnoid hemorrhage after mechanical thrombectomy.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe occurrence and impact of acute convexity subarachnoid hemorrhage (cSAH) in patients with acute ischemic stroke (AIS) caused by intracranial atherosclerotic (ICAS)-related large vessel occlusion (LVO) who underwent mechanical thrombectomy (MT) have rarely been reported.
methodsAIS patients with ICAS-related LVO who experienced acute cSAH after MT were enrolled. Data on demographic, baseline clinical information, perioperative radiological images, treatment, and prognosis of the patients were extracted and reviewed. The modified Rankin scale (mRS) score at 90 days was used to assess the prognosis, and an mRS score of 0-2 was considered to indicate a good prognosis.
resultsAmong 979 patients with acute ICAS-related LVO who underwent MT, 9 (0.92%) patients experienced cSAH (7 men, mean age 58 years). 4 (4/9, 44%) of patients were prescribed dual antiplatelet therapy while 5 (5/9, 56%) were prescribed single antiplatelet therapy for postoperative management. None of the patients experienced transformation to intracerebral hemorrhage. At 90 days, all nine patients (100%) had a good prognosis.
conclusionOur study showed that cSAH rarely occurs after MT in AIS patients with ICAS-related occlusion, and its occurrence does not appear to influence antiplatelet administration or patient prognosis.
Indexed as
Identifiers
40423884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.